{"id":520864,"date":"2026-04-09T05:29:25","date_gmt":"2026-04-09T05:29:25","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/520864\/"},"modified":"2026-04-09T05:29:25","modified_gmt":"2026-04-09T05:29:25","slug":"humiras-trumprx-discount-raises-new-questions-for-abbvie-valuation","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/520864\/","title":{"rendered":"Humira\u2019s TrumpRx Discount Raises New Questions For AbbVie Valuation"},"content":{"rendered":"\n

Get insights on thousands of stocks<\/a> from the global community of over 7 million individual investors at Simply Wall St.<\/p>\n

AbbVie is launching Humira on the TrumpRx platform with an 86% discount under a pricing agreement with the White House.<\/p>\n

The move is intended to lower out of pocket costs and expand access to the drug for US patients.<\/p>\n

This marks a shift in AbbVie\u2019s US pricing approach for one of its flagship therapies in the post exclusivity period.<\/p>\n

For investors tracking AbbVie (NYSE:ABBV), this pricing decision comes as the stock trades around $206.69, with a 1 year return of 14.5% and a 5 year return of 131.2%. The company is already a major player in immunology, and Humira has been central to that position, so any change to its pricing structure can matter for how the market views AbbVie\u2019s US business mix.<\/p>\n

The deep discount on TrumpRx could affect patient volumes, payer relationships, and how other high cost biologics are priced in government linked programs. Readers may want to watch how this agreement with the White House influences future pricing discussions, competitor responses in US biologics, and whether similar frameworks are extended to other AbbVie products.<\/p>\n

Stay updated on the most important news stories for AbbVie<\/a> by adding it to your watchlist<\/a> or portfolio<\/a>. Alternatively, explore our Community<\/a> to discover new perspectives on AbbVie.<\/p>\n

\"NYSE:ABBV<\/a> NYSE:ABBV Earnings & Revenue Growth as at Apr 2026 <\/p>\n

We’ve flagged 5 risks for AbbVie. See which could impact your investment.<\/a><\/p>\n

\u2705 Price vs Analyst Target: AbbVie trades around US$206.69 versus an analyst target of US$249.14, roughly 20% lower than consensus.<\/p>\n

\u2705 Simply Wall St Valuation: Shares are flagged as trading about 43.8% below an estimated fair value.<\/p>\n

\u274c Recent Momentum: The 30 day return is about a 10.2% decline, so short term sentiment has been weak.<\/p>\n

Investors looking to assess whether it is the right time to buy, sell, or hold AbbVie can review the latest data in Simply Wall St’s company report on AbbVie’s Fair Value<\/a>.<\/p>\n

\ud83d\udcca Launching Humira on TrumpRx at an 86% discount could influence AbbVie\u2019s US pricing mix and shape perceptions around drug affordability.<\/p>\n

\ud83d\udcca It may be useful to monitor how Humira volumes, the US$61.2b in revenue exposure, and the current P\/E of about 87.3 change as payers and patients respond to the lower list price.<\/p>\n

\u26a0\ufe0f AbbVie carries a high level of debt and a dividend yield of 3.35% that is not well covered by earnings, so investors may want to consider how this pricing shift could affect cash flows.<\/p>\n

For a more complete picture, including additional risks and potential opportunities, explore the complete AbbVie analysis<\/a>. You can also visit the community page for AbbVie<\/a> to see how other investors view the potential impact of this latest news on the company’s narrative.<\/p>\n

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.<\/p>\n

Companies discussed in this article include ABBV<\/a>.<\/p>\n

Have feedback on this article? Concerned about the content? Get in touch<\/a> with us directly. Alternatively, email editorial-team@simplywallst.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…\n","protected":false},"author":2,"featured_media":520865,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[47635,102,181201,48263,6591,181202,56,54,55,3285],"class_list":{"0":"post-520864","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-abbvie","9":"tag-health","10":"tag-humira","11":"tag-individual-investors","12":"tag-medication","13":"tag-pricing-decision","14":"tag-uk","15":"tag-united-kingdom","16":"tag-unitedkingdom","17":"tag-white-house"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/520864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=520864"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/520864\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/520865"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=520864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=520864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=520864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}